Additionally, changes in the expression of key secretases involved in App processing suggest that Ctsb may promote a shift toward non‐amyloidogenic App processing mediated by α‐secretase (such as ADAM10 and ADAM17) in the AD model (Figure S5e). Here, ADAM17 is linked to Alzheimer disease.